The Finnish Institute of Occupational Health, Helsinki, Finland.
N.N. Petrov Institute of Oncology.
Pharmacogenet Genomics. 2020 Aug;30(6):117-123. doi: 10.1097/FPC.0000000000000403.
Nicotine acts through the dopamine pathway in the brain affecting reward processing through cigarette consumption. Thus, both genetic and epigenetic factors related to dopamine metabolism may influence individual's smoking behavior.
We studied variations of two variable numbers of tandem repeats (VNTRs), 40 and 30 bp in length, in SLC6A3 gene together with six DNA methylation sites located in a first intron of the gene in relation to several smoking-related phenotypes in a study population consisting of 1230 Whites of Russian origin.
Both the 5R allele of 30 bp VNTR and the 9R allele of 40 bp VNTR in SLC6A3 were associated with a reduced risk to tobacco smoking [odds ratio (OR) 0.53, 95% confidence interval (CI) 0.37-0.75; OR 0.62, 95% CI 0.43-0.88]. Although the carriers of 9R allele also had high Fagerström test for nicotine dependence scores (OR 1.65, 95% CI 1.04-2.60), they were still more likely to succeed in smoking cessation (OR 0.59, 95% CI 0.40-0.88). Also, current smokers had more than 2.5-fold likelihood to have increased SLC6A3 methylation levels than former smokers (OR 2.72, 95% CI 1.63-4.53).
The SLC6A3 5R of 30 bp and 9R of 40 bp VNTR variants may lead to a reduced risk to start smoking through decreased dopamine availability, and can also affect the success in subsequent smoking cessation attempts. Moreover, the elevated mean methylation values in the first intron of SLC6A3 may be related to nicotine dependence via a more active dopamine transporter.
尼古丁通过大脑中的多巴胺途径发挥作用,通过吸烟影响奖励处理。因此,与多巴胺代谢相关的遗传和表观遗传因素可能会影响个体的吸烟行为。
我们研究了 SLC6A3 基因中两个长度分别为 40bp 和 30bp 的可变数目串联重复(VNTR)以及位于基因第一内含子中的六个 DNA 甲基化位点的变异与俄罗斯裔白人研究人群中的几个与吸烟相关的表型之间的关系。
SLC6A3 中的 30bpVNTR 的 5R 等位基因和 40bpVNTR 的 9R 等位基因均与降低吸烟风险相关[比值比(OR)0.53,95%置信区间(CI)0.37-0.75;OR0.62,95%CI0.43-0.88]。尽管携带 9R 等位基因的个体也具有较高的尼古丁依赖 Fagerström 测试评分(OR1.65,95%CI1.04-2.60),但他们仍更有可能成功戒烟(OR0.59,95%CI0.40-0.88)。此外,与曾经吸烟者相比,当前吸烟者的 SLC6A3 甲基化水平升高的可能性高出 2.5 倍以上(OR2.72,95%CI1.63-4.53)。
SLC6A3 中的 30bp 的 5R 和 40bp 的 9R VNTR 变体可能通过降低多巴胺的可用性导致开始吸烟的风险降低,并且还可能影响随后戒烟尝试的成功。此外,SLC6A3 第一内含子中升高的平均甲基化值可能通过更活跃的多巴胺转运体与尼古丁依赖有关。